Mitochondrial iron sequestration in dopamine-challenged astroglia: Role of heme oxygenase-1 and the permeability transition pore

Journal of Neurochemistry

Volumn 72, Issue 5, 1999, Pages 1802-1811

  Schipper, H M ^a,b   Bernier, L ^a   Mehindate, K ^a   Frankel, D ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Astrocyte; Heme oxygenase 1; Iron; Mitochondria; Oxidative stress; Parkinson's disease; Permeability transition pore

Indexed keywords

DOPAMINE; HEME OXYGENASE; IRON;

ANIMAL CELL; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; MACROGLIA; MITOCHONDRION; NERVE DEGENERATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALS; ASTROCYTES; CELLS, CULTURED; DOPAMINE; DOPAMINE AGENTS; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HYDROGEN PEROXIDE; INTRACELLULAR MEMBRANES; IRON; LEVODOPA; MITOCHONDRIA; NOREPINEPHRINE; OXIDANTS; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN K;

ANIMALIA;

EID: 0032970494     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0721802.x     Document Type: Article

References (54)

1. An G., Hidaka K., and Siminovitch L. (1982) Expression of bacterial β-galactosidase in animal cells. Mol. Cell. Biol. 2, 1628-1632.
2. Beal M. F. (1995) Mitochondrial Dysfunction in Neurodegenerative Diseases. R. G. Landes Co., Austin.
3. Bernardi P. (1996) The permeability transition pore. Control points of cyclosporin A-sensitive mitochondrial channel involved in cell death. Biochim, Biophys. Acta 1275, 5-9.
4. Broekemeier K. M. and Pfeiffer D. R. (1995) Inhibition of mitochondrial permeability transition by cyclosporin A during long time frame experiments: relationship between pore opening and the activity of mitochondrial phospholipases. Biochemistry 34, 16440-16449.
5. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
6. Chopra V. S., Chalifour L. E., and Schipper H. M. (1995) Differential effects of cysteamine on heat shock protein induction and cytoplasmic granulation in astrocytes and glioma cells. Mol. Brain Res. 31, 173-184.
7. Chopra V. S., Moozar K. L., Mehindate K., and Schipper H. M. (1997) A cellular stress model for the differential expression of glial lysosomal cathepsins in the aging nervous system. Exp. Neurol. 147, 221-228.
8. Church G. M. and Gilbert W. (1984) Genomic sequencing. Proc. Natl. Acad. Sci. USA 81, 1991-1995.
9. Connor J. R., Menzies S., St. Martin S. M., and Mufson E. J. (1990) Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J. Neurosci. 27, 595-611.
10. Connor J. R., Menzies S. L., St. Martin S. M., and Mufson E. J. (1992) A histochemical study of iron-transferrin and ferritin in Alzheimer's disease brains. J. Neurosci. Res. 31, 75-83.
11. Dexter D. T., Carter C. J., Wells F. R., Javoy-Agid F., Agid Y., Lees A., Jenner P., and Marsden C. D. (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52, 381-389.
12. Dwork A. J., Schon E. A., and Herbert J. (1988) Nonidentical distribution of transferrin and ferric iron in human brain. Neuroscience 27, 333-345.
13. 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease. J. Neurochem. 60, 2338-2341.
14. Faucheux B. A., Nillesse N., Damier P., Spik G., Mouatt-Prigent A., Pierce A., Leveugle B., Kubis N., Hauw J. J., Agid Y., and Hirsch E. C. (1995) Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson's disease. Proc. Natl. Acad. Sci. USA 92, 9603-9607.
15. 125-I]transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease. Brain Res. 749, 170-174.
16. Feinberg A. P. and Vogelstein B. (1984) A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 137, 266-267.
17. Frankel D. and Schipper H. M. (1997) Does astroglial senescence facilitate oxidative neuronal injury? Soc. Neurosci. Abstr. 23, 1371.
18. Geddes J. W., Pettigrew C., Holtz M. L., Craddock S. D., and Maines M. D. (1996) Permanent focal and transient global cerebral ischemia increase glial and neuronal expression of heme oxygenase-1, but not heme oxygenase-2, protein in rat brain. Neurosci. Lett. 210, 205-208.
19. Gelman B. B. (1995) Iron in CNS disease. J. Neuropathol. Exp. Neurol. 54, 477-486.
20. Good P. F., Olanow C. W., and Perl D. P. (1992) Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study. Brain Res. 593, 343-346.
21. Gutteridge J. M. (1992) Iron and oxygen radicals in brain. Ann. Neurol. 32, S16-S21.
22. Janetzky B., Reichmann H., Youdim M. B. H., and Riederer P. (1997) Iron and oxidative damage in neurodegenerative diseases, in Mitochondria and Free Radicals in Neurodegenerative Diseases (Beal M. F., Howell N., and Bodis-Wollner I., eds), pp. 407-421, Wiley, New York.
23. Jellinger P., Paulus W., Grundke-Iqbal I., Riederer P., and Youdim M. B. H. (1990) Brain iron and ferritin in Parkinson's and Alzheimer's disease. J. Neural Transm. 2, 327-340.
24. Jenner P. (1992) What process causes nigral cell death in Parkinson's disease? in Neurological Clinics, Vol. 10, Pt. 2: Parkinson's Disease (Cederbaum J. M. and Gancher S. T., eds), pp. 387-403. Saunders, Philadelphia.
25. Kalaria R. N., Sromek S. M., Grahovac I., and Harik S. I. (1992) Transferrin receptors of rat and human brain and cerebral microvessels and their status in Alzheimer's disease. Brain Res. 585, 87-93.
26. Klausner R. D., Van Renswoude J., Ashwell G., Kempt C., Schechter A. N., Dean A., and Bridges K. R. (1983) Receptor-mediated endocytosis of transferrin in K562 cells. J. Biol. Chem. 258, 4717-4724.
27. Leveugle B., Faucheux B. A., Bouras G, Nillesse N., Spik G., Hirsch E. C., Agid Y., and Hof P. R. (1996) Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases. Acta Neuropathol. (Berl.) 91, 566-572.
28. Li C. L., Werner P., and Cohen G. (1995) Lipid peroxidation in brain: interactions of L-DOPA/dopamine with ascorbate and iron. Neurodegeneration 4, 147-153.
29. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurements with the Folin phenol reagent. J. Biol. Chem. 193, 265-272.
30. Manganaro F., Chopra V. S., Mydlarski M. B., Bernatchez G., and Schipper H. M. (1995) Redox perturbations in cysteamine-stressed astroglia: implications for inclusion formation and gliosis in the aging brain. Free Radic. Biol. Med. 19, 823-835.
31. Mash D. C., Pablo J., Buck B. E., Sanchez-Ramos J., and Weiner W. J. (1991) Distribution and number of transferrin receptors in Parkinson's disease and in MPTP-treated mice. Exp. Neurol. 114, 73-81.
32. Mash D. C., Sanchez-Ramos J., and Einer W. J. (1993) Transferrin receptor regulation in Parkinson's disease and MPTP-treated mice, in Advances in Neurology, Vol. 60 (Narabayashi H., Nagatsu T., Xanagisawa N., and Maurino Y., eds), pp. 133-139. Raven Press, New York.
33. Mickelson J. R., Greaser M. L., and Marsh B. B. (1980) Purification of skeletal-muscle mitochondria by density gradient centrifugation with Percoll. Anal. Biochem. 109, 255-260.
34. Morris C. M. and Edwardson J. A. (1994) Iron histochemistry of the substantia nigra in Parkinson's disease. Neurodegeneration 3, 277-282.
35. Mydlarski M. B., Liang J.-J., and Schipper H. M. (1993) Role of the cellular stress response in the biogenesis of cysteamine-induced astrocytic inclusions in primary culture. J. Neurochem. 61, 1755-1765.
36. Noonberg S. B., Scott G. K., Hunt C. A., and Benz C. C. (1994) Detection of triplex-forming RNA oligonucleotides by triplex blotting. Biotechniques 16, 1070-1072.
37. Olanow C. W. (1992) Magnetic resonance imaging in parkinsonism, in Neurological Clinics, Vol. 10, Pt. 2: Parkinson's Disease (Cederbaum J. M. and Gancher S. T., eds), pp. 405-420. Saunders, Philadelphia.
38. Oubidar M., Boquillon M., Marie C., Schreiber L., and Bralet J. (1994) Ischemia-induced brain iron delocalization: effect of iron chelators. Free Radic. Biol. Med. 16, 861-867.
39. Petronilli V., Cola C., Massari S., Colonna R., and Bernardi P. (1993) Physiological effectors modify voltage sensing by the cyclosporin A-sensitive permeability transition pore of mitochondria. J. Biol. Chem. 268, 21939-21945.
40. Ponka P. and Schulman H. M. (1985) Acquisition of iron from transferrin regulates reticulocyte heme synthesis. J. Biol. Chem. 260, 14717-14721.
41. Ponka P., Wilczynska A., and Schulman H. M. (1982) Iron utilization in rabbit reticulocytes. A study using succinylacetone as an inhibitor of heme synthesis. Biochim. Biophys. Acta 720, 96-105.
42. Reichmann H. and Riederer P. (1994) Mitochondrial disturbances in neurodegeneration, in Neurodegenerative Diseases (Calne D. B., ed), pp. 195-204. Saunders, Philadelphia.
43. Richardson D. and Baker E, (1991) The uptake of inorganic iron complexes by human melanoma cells. Biochim. Biophys. Acta 1093, 20-28.
44. Richardson D. R. and Ponka P. (1997) The molecular mechanisms of the metabolism and the transport of iron in normal and neoplastic cells. Biochim. Biophys. Acta 1331, 1-40.
45. Riederer P., Sofic E., Rausch W. D., Schmidt B., Reynolds G. P., Jellinger K., and Youdim M. B. H. (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 52, 515-520.
46. Schipper H. M. (1996) Astrocytes, brain aging and neurodegeneration. Neurobiol. Aging 17, 467-480.
47. Schipper H. M., Kotake Y., and Janzen E. G. (1991) Catechol oxidation by peroxidase-positive astrocytes in primary culture: an electron spin resonance study. J. Neurosci. 11, 2170-2176.
48. Schipper H. M., Cissé S., and Stopa E. G. (1995) Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann. Neurol. 37, 758-768.
49. Schipper H. M., Liberman A., and Stopa E. G. (1998) Neural heme oxygenase-1 expression in idiopathic Parkinson's disease. Exp. Neurol. 150, 60-68.
50. Stocker R. (1990) Induction of heme oxygenase as a defence against oxidative stress. Free Radic. Res. Commun. 9, 101-112.
51. Wang X., Manganaro F., and Schipper H. M. (1995) A cellular stress model for the sequestration of redox-active glial iron in the aging and degenerating nervous system. J. Neurochem. 64, 1868-1877.
52. Youdim M. B. H. (1994) Inorganic neurotoxins in neurodegenerative disorders without primary dementia, in Neurodegenerative Diseases (Calne D. B., ed), pp. 251-276. Saunders, Philadelphia.
53. Youdim M. B. H., Ben-Shachar D., and Riederer P. (1993) The possible role of iron in etiopathology of Parkinson's disease. Mov. Disord. 8, 1-12.
54. Zhang J. and Piantadosi C. A. (1992) Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain. J. Clin. Invest. 90, 1193-1199.